Mitral stenosis with severe pulmonary hypertension

S S Kabbani1, T Bashour, R Dunlap

  • 1Cardiovascular Surgical Center, Damascus Medical School, Damascus, Syria.

Insights

Severe mitral stenosis can cause high pulmonary artery pressures, leading to pulmonary hypertension or low cardiac output. Surgical intervention offers potential for good long-term outcomes in select patients.

Area of Science:

  • Cardiology
  • Pulmonary Hypertension
  • Valvular Heart Disease

Background:

  • Mitral valve disease is a significant cause of cardiac morbidity.
  • Pulmonary hypertension is a serious complication of mitral stenosis.
  • High pulmonary artery pressures impact patient prognosis and management.

Purpose of the Study:

  • To investigate the clinical presentation and outcomes of patients with mitral stenosis and severe pulmonary hypertension.
  • To evaluate the efficacy of surgical interventions in this patient cohort.

Main Methods:

  • Retrospective analysis of 512 patients with mitral valve disease undergoing catheterization.
  • Identification of 85 patients with mitral stenosis and systolic pulmonary artery pressures >= 100 mm Hg.
  • Review of surgical procedures and perioperative management, including nitroprusside infusion.

Main Results:

  • 85 patients had mitral stenosis with severe pulmonary hypertension (>= 100 mm Hg).
  • Majority presented with New York Heart Association Class IV (51.8%) or Class III (35.3%) symptoms.
  • Pulmonary hypertension symptoms were prominent in 56.5%; low cardiac output syndrome in the remainder.
  • 40 patients underwent surgery (commissurotomy, mitral valve replacement, double valve replacement).
  • Overall operative mortality was 15%; good long-term results in 30 patients.

Conclusions:

  • Mitral stenosis with severe pulmonary hypertension presents with significant symptoms and carries a high operative risk.
  • Surgical management, including valve repair or replacement, can lead to good long-term outcomes in carefully selected patients.
  • Perioperative support, such as nitroprusside infusion, may improve survival in critical cases.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...